Back to today’s briefing

Story perspectives

80+ Companies Race to Innovate Obesity Therapies

6/22/2025

40 2

Summary

Story summary

A groundbreaking report from DelveInsight reveals that more than 80 companies are racing to develop over 100 innovative therapies for obesity. Among the frontrunners, Zealand Pharma and Boehringer Ingelheim stand out, with promising candidates like Survodutide and CT-868 making waves in clinical trials. This evolving landscape showcases the relentless pursuit of effective obesity management solutions.

1 of 1

Story summary

A groundbreaking report from DelveInsight reveals that more than 80 companies are racing to develop over 100 innovative therapies for obesity. Among the frontrunners, Zealand Pharma and Boehringer Ingelheim stand out, with promising candidates like Survodutide and CT-868 making waves in clinical trials. This evolving landscape showcases the relentless pursuit of effective obesity management solutions.